George W. Lloyd

Insider Reports History

Entity
Individual
Location
C/O Royalty Pharma Plc, 110 East 59 Th Street, New York, NY
Signature
/s/ Sean Weisberg, as Attorney-in-Fact for George W. Lloyd
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by George W. Lloyd:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Royalty Pharma plc EVP, Investments & CLO Class A Ordinary Shares 496K $13.7M $27.55 Nov 13, 2023 By GWL 2013 NG, LLC
Royalty Pharma plc EVP, Investments & CLO Class A Ordinary Shares 274K $7.55M $27.55 Nov 13, 2023 By IRA
Royalty Pharma plc EVP, Investments & CLO Class A Ordinary Shares 220K $6.06M $27.55 Nov 13, 2023 By GWL 2014 G, LLC
Royalty Pharma plc EVP, Investments & CLO Class A Ordinary Shares 80K $2.2M $27.55 Nov 13, 2023 By GWL 2020 G, LLC
Royalty Pharma plc EVP, Investments & CLO Class A Ordinary Shares 4.01K $110K $27.55 Nov 13, 2023 By Spouse
Royalty Pharma plc EVP, Investments & CLO Class A Ordinary Shares 3K $82.6K $27.55 Nov 13, 2023 Direct
Royalty Pharma plc EVP, Investments & CLO LP interests in RPI US Partners 2019, LP 163K Aug 12, 2024 By GWL 2014 G, LLC
Royalty Pharma plc EVP, Investments & CLO LP interests in RPI US Partners 2019, LP 139K Aug 12, 2024 By GWL 2021 G LLC
Royalty Pharma plc EVP, Investments & CLO LP interests in RPI US Partners 2019, LP 98.6K Aug 12, 2024 By GWL 2020 G, LLC
Royalty Pharma plc EVP, Investments & CLO LP interests in RPI US Partners 2019, LP 8.17K Aug 12, 2024 By GWL 2013 NG, LLC
Royalty Pharma plc EVP, Investments & CLO LP interests in RPI US Partners 2019, LP 0 Aug 12, 2024 Direct

Insider Reports Filed by George W. Lloyd

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RPRX Royalty Pharma plc Aug 12, 2024 1 $0 4 Aug 12, 2024 EVP, Investments & CLO
RPRX Royalty Pharma plc Nov 13, 2023 4 $0 4 Nov 14, 2023 EVP, Investments & CLO
RPRX Royalty Pharma plc Aug 8, 2023 1 $0 4 Aug 8, 2023 EVP, Investments & CLO
RPRX Royalty Pharma plc Jun 2, 2023 4 -$6.48M 4 Jun 6, 2023 EVP, Investments & CLO
RPRX Royalty Pharma plc Mar 28, 2023 2 -$4.18M 4 Mar 30, 2023 EVP, Investments & CLO
RPRX Royalty Pharma plc Feb 23, 2023 1 -$932K 4 Feb 27, 2023 EVP, Investments & CLO
RPRX Royalty Pharma plc Nov 21, 2022 4 -$1.73M 4 Nov 22, 2022 EVP, Investments & CLO
RPRX Royalty Pharma plc Nov 10, 2022 3 -$2.19M 4 Nov 14, 2022 EVP, Investments & CLO
RPRX Royalty Pharma plc Aug 9, 2022 2 -$916K 4 Aug 11, 2022 EVP, Investments & GC
RPRX Royalty Pharma plc Jul 28, 2022 1 -$178K 4 Aug 1, 2022 EVP, Investments & GC
RPRX Royalty Pharma plc Jul 25, 2022 6 -$3.25M 4 Jul 27, 2022 EVP, Investments & GC
RPRX Royalty Pharma plc May 26, 2022 2 -$4.03M 4 May 31, 2022 EVP, Investments & GC
RPRX Royalty Pharma plc May 23, 2022 1 -$4.03M 4 May 25, 2022 EVP, Investments & GC
RPRX Royalty Pharma plc Nov 16, 2021 5 -$10.6M 4 Nov 18, 2021 EVP, Investments & GC
RPRX Royalty Pharma plc Jul 26, 2021 2 -$532K 4 Jul 27, 2021 EVP, Investments & GC
RPRX Royalty Pharma plc Jul 12, 2021 3 -$972K 4 Jul 14, 2021 EVP, Investments & GC
RPRX Royalty Pharma plc Jul 6, 2021 6 -$3.73M 4 Jul 8, 2021 EVP, Investments & GC
RPRX Royalty Pharma plc Jun 10, 2021 3 -$3.25M 4 Jun 14, 2021 EVP, Investments & GC
RPRX Royalty Pharma plc Jun 4, 2021 12 -$11.6M 4 Jun 8, 2021 EVP, Investments & GC
RPRX Royalty Pharma plc Jun 2, 2021 2 -$2.63M 4 Jun 4, 2021 EVP, Investments & GC
RPRX Royalty Pharma plc May 7, 2021 6 $0 4 May 11, 2021 EVP, Investments & GC